Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical efficacy of Filgrastim-AryaTinaGene in neutropenia
IRCT2013062613776N1Phase 3Completed
- Sponsor
- AryaTinaGene
- Start
- Jul 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of filgrastim in neutropenia, sponsored by AryaTinaGene. Started Jul 2013; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on IRCT2013062613776N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013062613776N1.